Clinical experience shows improved tumor assessment in various cancers using 68Ga-FAPI PET/CT, suggesting broad implications.
⁶⁸Ga-FAPI-46 PET/CT provides high-contrast imaging across a wide spectrum of malignancies, demonstrating particularly strong potential for visualizing tumors with prominent stromal components. These findings suggest a significant clinical role for this modality in improving tumor staging, restaging, and therapy assessment, especially in cases where ¹⁸F-FDG PET/CT is suboptimal.
No takes yet. Share an insight, caveat, or question.
AL-TIMEEMI et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: